These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2071787)

  • 1. Inhibition of cutaneous and platelet responses to platelet-activating factor by oral WEB 2086 in man.
    Hayes JP; Ridge SM; Griffith S; Barnes PJ; Chung KF
    J Allergy Clin Immunol; 1991 Jul; 88(1):83-8. PubMed ID: 2071787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor.
    Heuer HO; Casals-Stenzel J; Muacevic G; Weber KH
    J Pharmacol Exp Ther; 1990 Dec; 255(3):962-8. PubMed ID: 2262914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the actions of platelet activating factor (PAF) antagonists WEB 2170 and WEB 2086 in the horse.
    Foster AP; Cunningham FM; Andrews MJ; Lees P
    J Vet Pharmacol Ther; 1993 Dec; 16(4):477-87. PubMed ID: 8126765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of WEB 2086, an antagonist to the receptor for platelet-activating factor (PAF), on PAF-induced responses in the horse.
    Foster AP; Lees P; Andrews MJ; Cunningham FM
    Equine Vet J; 1992 May; 24(3):203-7. PubMed ID: 1318830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological activities of a novel thienodiazepine derivative as a platelet-activating factor antagonist.
    Tsunoda H; Sakuma Y; Harada K; Muramoto K; Katayama S; Horie T; Shimomura N; Clark R; Miyazawa S; Okano K
    Arzneimittelforschung; 1990 Nov; 40(11):1201-5. PubMed ID: 2085331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PAF-induced platelet aggregation ex vivo as a method for monitoring pharmacological activity in healthy volunteers.
    Adamus WS; Heuer H; Meade CJ
    Methods Find Exp Clin Pharmacol; 1989 Jun; 11(6):415-20. PubMed ID: 2747341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological actions of Y-24180, a new specific antagonist of platelet activating factor (PAF): II. Interactions with PAF and benzodiazepine receptors.
    Takehara S; Mikashima H; Muramoto Y; Terasawa M; Setoguchi M; Tahara T
    Prostaglandins; 1990 Dec; 40(6):571-83. PubMed ID: 1965554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effect of oral WEB 2086, a novel selective PAF-acether antagonist, on ex vivo platelet aggregation.
    Adamus WS; Heuer H; Meade CJ; Frey G; Brecht HM
    Eur J Clin Pharmacol; 1988; 35(3):237-40. PubMed ID: 3181277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined effect of Web 2086 (Paf antagonist) and ketoprofen (Nsaid) on Paf-induced ex vivo platelet aggregation in bovine.
    Bastos da Silva M; Herion F; Raskinet R; David JL; Gustin P; Lekeux P
    Zentralbl Veterinarmed A; 1997 Apr; 44(2):65-71. PubMed ID: 9284631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Y-24180, a long-acting antagonist to platelet-activating factor (PAF), on PAF-induced reactions: a relationship between the partial structure of the compound and its duration of the action.
    Kagoshima M; Tomomatsu N; Iwahisa Y; Yamaguchi S; Kawakami Y; Terasawa M
    Pharmacology; 1997 May; 54(5):261-70. PubMed ID: 9380772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a ginkgolide mixture (BN 52063) in antagonising skin and platelet responses to platelet activating factor in man.
    Chung KF; Dent G; McCusker M; Guinot P; Page CP; Barnes PJ
    Lancet; 1987 Jan; 1(8527):248-51. PubMed ID: 2880069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of PAF-induced platelet aggregation by WEB 2086 'in-vitro', an antagonist to the receptor for platelet-activating factor, in bovine.
    da Silva MB; Herion F; Raskinet R; David JL; Gustin P; Dessy C; Lekeux P
    Zentralbl Veterinarmed A; 1996 Sep; 43(7):399-413. PubMed ID: 8921726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of intravenous administration of WEB 2086 on PAF-induced platelet aggregation in healthy Friesian calves.
    Bastos da Silva MB; Gustin P; Herion F; Raskinet R; David JL; Gougnard T; Plomteux G; Desmecht D; Lekeux P
    Vet Res Commun; 1997 Oct; 21(7):521-31. PubMed ID: 9345719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of rupatadine at four times the recommended dose against histamine- and platelet-activating factor-induced flare responses and ex vivo platelet aggregation in healthy males.
    Church MK
    Br J Dermatol; 2010 Dec; 163(6):1330-2. PubMed ID: 20819087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet-activating factor (PAF) receptor antagonists inhibit arachidonic acid induced platelet aggregation in rabbit whole blood.
    Ammit AJ; O'Neill C
    Lipids; 1991 Dec; 26(12):1189-92. PubMed ID: 1668116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological actions of WEB 2086, a new specific antagonist of platelet activating factor.
    Casals-Stenzel J; Muacevic G; Weber KH
    J Pharmacol Exp Ther; 1987 Jun; 241(3):974-81. PubMed ID: 3598913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of platelet-activating factor-induced cutaneous edema and erythema in dogs.
    Watanabe M; Osada H; Shimizu S; Goto S; Nagai M; Shirai J; Sasaki K; Shimoda M; Itoh H; Ohmori K
    Am J Vet Res; 2016 Sep; 77(9):969-75. PubMed ID: 27580108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical and pharmacological activities of SR 27417, a highly potent, long-acting platelet-activating factor receptor antagonist.
    Herbert JM; Bernat A; Valette G; Gigo V; Lale A; LaPlace MC; Lespy L; Savi P; Maffrand JP; Le Fur G
    J Pharmacol Exp Ther; 1991 Oct; 259(1):44-51. PubMed ID: 1656029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1-O-hexadecyl-2-metoxy-glycero-3-phosphatidylcholine--a methoxy ether lipid inhibiting platelet activating factor-induced platelet aggregation and neutrophil oxidative metabolism.
    Le Blanc K; Samuelsson J; Brohult J; Berg A; Palmblad J
    Biochem Pharmacol; 1995 May; 49(11):1577-82. PubMed ID: 7786298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitor effect of apafant on bronchopulmonary responses to platelet activating factor and to antigen in rats.
    Akagi M; Nishioka E; Kanoh R; Tachibana M; Fukuishi N
    Arzneimittelforschung; 1997 Dec; 47(12):1364-9. PubMed ID: 9450165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.